Amy Rabourn
2021
In 2021, Amy Rabourn earned a total compensation of $332.1K as Vice President of Finance at Rexahn Pharmaceuticals, a 25% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $67,680 |
|---|---|
| Salary | $240,000 |
| Other | $24,413 |
| Total | $332,093 |
Rabourn received $240K in salary, accounting for 72% of the total pay in 2021.
Rabourn also received $67.7K in non-equity incentive plan and $24.4K in other compensation.
Rankings
In 2021, Amy Rabourn's compensation ranked 11,478th out of 12,415 executives tracked by ExecPay. In other words, Rabourn earned more than 7.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,478 out of 12,415 | 8th |
Division Manufacturing | 5,051 out of 5,508 | 8th |
Major group Chemicals And Allied Products | 2,240 out of 2,378 | 6th |
Industry group Drugs | 1,990 out of 2,099 | 5th |
Industry Pharmaceutical Preparations | 1,472 out of 1,549 | 5th |
Source: SEC filing on April 27, 2022.
Rabourn's colleagues
We found two more compensation records of executives who worked with Amy Rabourn at Rexahn Pharmaceuticals in 2021.